Slow Bull
The market, slowly. SATURDAY, 26 SEPTEMBER 2026

Connect Biopharma Holdings Ltd

CNTB Nasdaq SEC CIK 1835268
Follow Connect Biopharma Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2024 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income4 fiscal years
−$300M−$200M−$100M$0FY20FY21FY22FY23
Show the numbers
YearNet income
FY23−$59.5M
FY22−$118.1M
FY21−$202.3M
FY20-
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY20FY21FY22FY23
Show the numbers
YearFree cash flow
FY23−$48.2M
FY22−$105.9M
FY21−$88.2M
FY20-
Returned to shareholdersDividends paid and shares bought back
$0$200K$400K$600KFY20FY21FY22FY23
Show the numbers
YearBuybacks
FY23$0
FY22$0
FY21$566K
FY20-

News

No stories filed under Connect Biopharma yet - coverage appears here as the news feed clusters it.